FI833369A - -ARYL- -PYRIDYLALKANSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION - Google Patents

-ARYL- -PYRIDYLALKANSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION Download PDF

Info

Publication number
FI833369A
FI833369A FI833369A FI833369A FI833369A FI 833369 A FI833369 A FI 833369A FI 833369 A FI833369 A FI 833369A FI 833369 A FI833369 A FI 833369A FI 833369 A FI833369 A FI 833369A
Authority
FI
Finland
Prior art keywords
sup
lower alkyl
aryl
pharmaceutical composition
hydrogen
Prior art date
Application number
FI833369A
Other languages
Finnish (fi)
Other versions
FI80878B (en
FI80878C (en
FI833369A0 (en
Inventor
Ikuo Ueda
Masanobu Nagano
Atsushi Akahane
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI833369A0 publication Critical patent/FI833369A0/en
Publication of FI833369A publication Critical patent/FI833369A/en
Publication of FI80878B publication Critical patent/FI80878B/en
Application granted granted Critical
Publication of FI80878C publication Critical patent/FI80878C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

New a-aryl-a-pyridylalkanoic acid derivatives of the formula:whereinR<sup>1</sup> is cyano or carbamoyl,R<sup>2</sup> is hydrogen or halogen,R<sup>3</sup> is hydrogen or lower alkyl,one of R<sup>4</sup> and R<sup>5</sup> is hydrogen and another is lower alkyl,R<sup>6</sup> is hydrogen or lower alkyl, andR<sup>7</sup> is lower alkyl, orR<sup>6</sup> and R<sup>7</sup> are taken together to form an N-containing saturated heterocyclic group with the adjacent nitrogen atom, in which the heterocyclic group may be substituted with lower alkyl or optionally protected hydroxy(lower)alkyl, provided that R<sup>2</sup> is halogen or R<sup>3</sup> is lower alkyl, when R<sup>1</sup> is cyano and R<sup>6</sup> and R<sup>7</sup> are each lower alkyl, and salts thereof, and processes for preparation thereof and pharmaceutical composition comprising the same.These derivatives and salts thereof are useful as antiulcer agents and spasmolytic agents.
FI833369A 1982-09-30 1983-09-21 Process for the Preparation of Pharmacologically Useful -arylpyridylalkanoic Acid Derivatives FI80878C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57172936A JPS5980664A (en) 1982-09-30 1982-09-30 Alpha-aryl-alpha-pyridylfatty acid derivative and preparation thereof
JP17293682 1982-09-30

Publications (4)

Publication Number Publication Date
FI833369A0 FI833369A0 (en) 1983-09-21
FI833369A true FI833369A (en) 1984-03-31
FI80878B FI80878B (en) 1990-04-30
FI80878C FI80878C (en) 1990-08-10

Family

ID=15951089

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833369A FI80878C (en) 1982-09-30 1983-09-21 Process for the Preparation of Pharmacologically Useful -arylpyridylalkanoic Acid Derivatives

Country Status (14)

Country Link
US (1) US4564621A (en)
EP (1) EP0105458B1 (en)
JP (1) JPS5980664A (en)
KR (1) KR900004694B1 (en)
AT (1) ATE48130T1 (en)
CA (1) CA1246573A (en)
DE (1) DE3380876D1 (en)
DK (1) DK157854C (en)
ES (1) ES8603421A1 (en)
FI (1) FI80878C (en)
GR (1) GR78525B (en)
HU (1) HU193046B (en)
NO (1) NO162017C (en)
ZA (1) ZA837069B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60112762A (en) * 1983-11-21 1985-06-19 Fujisawa Pharmaceut Co Ltd Alpha-aryl-alpha-pyridyl fatty acid derivative and production thereof
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4783537A (en) * 1985-11-13 1988-11-08 Pennwalt Corporation α-(aminoalkyl)-arylacetic acid derivatives
US5202331A (en) * 1990-04-18 1993-04-13 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
CA2436323C (en) * 2001-01-24 2012-02-21 Cadila Healthcare Ltd. Process for preparing clopidogrel
CA2796877A1 (en) 2010-04-30 2011-11-03 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA501690A (en) * 1954-04-20 Schering Corporation Pyridyl substituted alkanes
NL70757C (en) * 1947-10-13
FR1235903A (en) * 1954-06-04 1960-11-10 Pharmacia Ab Process for the preparation of butyril amides
US2991289A (en) * 1958-02-05 1961-07-04 Merck Ag E Derivatives of 1-aminopropane
GB915804A (en) * 1958-04-12 1963-01-16 Degussa Process for the production of basically substituted carboxylic acid amides
FR2485M (en) * 1961-05-17 1964-04-27 Searle & Co New heart regulators.
US3225054A (en) * 1962-07-03 1965-12-21 Searle & Co 4-dipropylamino-2-aryl-2-pyridylalkanamides
JPS5248862B2 (en) * 1971-08-16 1977-12-13

Also Published As

Publication number Publication date
FI80878B (en) 1990-04-30
HU193046B (en) 1987-08-28
ES526026A0 (en) 1985-12-16
ATE48130T1 (en) 1989-12-15
NO162017B (en) 1989-07-17
KR840006238A (en) 1984-11-22
US4564621A (en) 1986-01-14
ES8603421A1 (en) 1985-12-16
DK157854B (en) 1990-02-26
DK421183A (en) 1984-03-31
KR900004694B1 (en) 1990-07-02
GR78525B (en) 1984-09-27
NO162017C (en) 1989-10-25
NO833529L (en) 1984-04-02
CA1246573A (en) 1988-12-13
FI80878C (en) 1990-08-10
FI833369A0 (en) 1983-09-21
EP0105458A2 (en) 1984-04-18
EP0105458B1 (en) 1989-11-23
ZA837069B (en) 1984-05-30
JPS5980664A (en) 1984-05-10
JPS635025B2 (en) 1988-02-01
EP0105458A3 (en) 1985-11-27
DE3380876D1 (en) 1989-12-28
DK421183D0 (en) 1983-09-15
DK157854C (en) 1990-07-23

Similar Documents

Publication Publication Date Title
ES8300112A1 (en) their starting compounds and their preparation.
FI810604L (en) FOERFARANDE FOER FRAMSTAELLNING AV INDANDERIVAT
ES8600264A1 (en) New furanone derivatives, process for the preparation thereof and use thereof.
JPS5432460A (en) Cycloalkylidenemethylphenylacetic acid derivative and their preparation
IT1144033B (en) TRICYCLIC DERIVATIVES AND THEIR PHARMACOLOGICALLY ACTIVE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AS WELL AS PROCEDURE FOR THEIR PREPARATION
ATE59632T1 (en) DIHYDRODIBENZOCYCLOHEPTYLIDENETHYLAMINE DERIVATIVES
ES8704917A1 (en) 1-Piperazine carboxamide derivatives, their preparation and their use in pharmaceutical compositions.
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
FI833369A (en) -ARYL- -PYRIDYLALKANSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
ES8106003A1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them.
ES8200871A1 (en) Substituted 2-amino-3,4-dihydropyridine derivatives, their preparation and use as medicaments.
IL72330A (en) 3-alkyl-7-pyridyl-1h-triazolo(3,4-a)pyrimidine-5-one derivatives,their preparation and pharmaceutical compositions containing them
NO802925L (en) NITROSOURE ADDITIVES AND PROCEDURES FOR PREPARING THEREOF
DK601383D0 (en) piperidine
JPS5649359A (en) Carbostyril derivative
DK601983A (en) AMINOETHOXYBENZYL ALCOHOL DERIVATIVES
JPS5714578A (en) 2-benzimidazolinone derivative
JPS5219637A (en) Preparation of novel biscarboxylic acid esters
JPS5219654A (en) Preparation of ng-substituted-n2- substituted-alginamides and acid add ition salts thereof
JPS55104266A (en) Novel pyridone derivative
JPS5231061A (en) Preparation of n2- naphthalenesulfonylalginamides or acid addition sal ts thereof
SE7905025L (en) TEREFTALIC ACID MONOAMIDE DERIVATIVE, PROCEDURE FOR THE PREPARATION AND ANTIALLERGIC
JPS5350194A (en) 77 44*alkanesulfoneamidephenyl**55oxoimidazolidinyl 33methyll 33cephemm44ca rboxlic acid derivatives
JPS5436252A (en) Novel propano-anthracene derivatives and their preparation
ES8506012A1 (en) Acridanone derivatives.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.